GlassScriptPhysician profile
David George Mckenzie
NPI 1245541937
$7,570.39
in general payments reported to CMS, 2019-2025
33 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,271 · 2020: $93.97 · 2021: $254 · 2022: $259 · 2023: $358 · 2024: $1,290 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200 · Travel and Lodging: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,199.58 |
| Travel and Lodging | $492.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,400.42 | 2019-2025 | Augment Injectable, 7 X 23mm Citrelock Implant, Variax |
| Paragon 28, INC. | $1,050.79 | 2024-2025 | Portfolio, Precision Mis Bunion, Baby Gorilla |
| Boston Scientific Corporation | $209.88 | 2019 | |
| Celularity INC. | $178.00 | 2019 | |
| Sanara Medtech INC. | $165.56 | 2025 | Celleraterx |
| Orthofix Medical, INC. | $147.59 | 2024-2025 | Physio-Stim |
| Anika Therapeutics, INC. | $145.70 | 2021 | |
| Bone Support INC. | $144.90 | 2025 | Ceramentbone Void Filler, Cerament G |
| Smith+Nephew, INC. | $127.34 | 2021-2025 | Stravix, Grafix Pl |
| Nevro Corp. | $118.19 | 2022-2023 | Senza |
| Ani Pharmaceuticals, INC. | $86.90 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $84.34 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $74.14 | 2025 | |
| Treace Medical Concepts, INC. | $72.30 | 2022-2025 | |
| Allergan, INC. | $59.73 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $59.44 | 2022-2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.67 | 2020-2021 | |
| Polarityte, INC. | $39.16 | 2019-2020 | |
| Djo, LLC | $36.36 | 2019 | |
| Solventum Corporation | $34.43 | 2024 | Prevena, V.A.C. Veraflo |
| Horizon Therapeutics Plc | $34.43 | 2023 | Krystexxa |
| Polynovo North America LLC | $32.70 | 2024-2025 | Novosorb Btm |
| Medtronic, INC. | $30.90 | 2022-2025 | Inceptiv |
| Kci USA, INC. | $30.65 | 2020-2023 | Activ.A.C., V.A.C. Veraflo |
| Alfasigma USA, INC. | $29.01 | 2021-2022 | |
| Tactile Systems Technology INC | $27.77 | 2020-2025 | Nimbl, Flexitouch Plus |
| Organogenesis INC. | $25.20 | 2022 | |
| Amgen INC. | $20.14 | 2024 | Krystexxa |
| Ethicon US, LLC | $16.61 | 2022 | |
| Trice Medical, INC. | $15.53 | 2023 | |
| Integra Lifesciences Corporation | $13.49 | 2023 | Tcc-Ez |
| Bioventus LLC | $11.30 | 2020 | |
| Dynasplint Systems INC. | $6.82 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.